探索基托桑作为甲状腺的有希望的载体,对抗癌症的潜力
Haitham Amin1, Gamal Zayed2, Islam M Ibrahim3
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.
International journal of biological macromolecules
|May 14, 2025
概括
酸盐 (CS) 和甲酸盐 (MTX) 提供了一种新的癌症治疗方法. 这种药物递送系统利用CS向癌细胞,改善了超越传统化疗的治疗选择.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 药物输送系统 药物输送系统
背景情况:
- 癌症仍然是全球死亡的主要原因,乳腺癌,肺癌,结肠直肠癌和前列腺癌是最普遍的.
- 传统的癌症治疗方法,如化疗,放射治疗和手术,会造成严重的伤害和副作用.
- 需要先进的药物输送系统来提高癌症治疗效率和降低毒性.
研究的目的:
- 探索酸盐 (CS) 作为甲状腺酸盐 (MTX) 在癌症治疗中的药物递送载体的潜力.
- 研究基于CS的传递系统的各种配方,以提高癌细胞中的MTX沉积.
- 评估CS-MTX系统作为传统化疗和新型向药物输送之间的桥梁.
主要方法:
- 酸盐 (CS) 用于制定各种纳米结构,包括纳米细胞,水凝和纳米粒子 (NP).
- CS被用作金属和蛋白质NP的涂层材料,以改善药物输送.
- 用氨酸或叶酸对CS进行表面修改,以探索活性癌细胞向.
主要成果:
- CS在创建MTX的多样化交付平台方面表现出多样性,例如纳米粒子和水凝.
- 用向配体对CS的表面功能化增强了其积极将MTX导向癌细胞的潜力.
- 结合的CS-MTX系统在克服传统癌症治疗的局限性方面显示出有前途.
结论:
- 素-MTX系统代表了癌症药物递送的有前途的进步,提供了一种新的治疗策略.
- 这些系统有可能减轻与传统癌症治疗相关的严重副作用.
- 基于CS的药物递送为改善癌症治疗结果和扩大治疗选择提供了一条新的途径.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
09:56Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
14.8K
相关概念视频
Phase II Reactions: Methylation Reactions
104
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
104
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
